tiprankstipranks
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
ERMA
Enorama Pharma AB
RESEARCH TOOLSreports

Enorama Pharma AB (ERMA) Cash flow

0 Followers

Enorama Pharma AB Cash Flow

SE:ERMA's free cash flow for Q4 2025 was kr0.00. For the 2025 fiscal year, SE:ERMA's free cash flow was decreased by kr35.70M and operating cash flow was kr-14.79M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -59.26Mkr -35.70Mkr -41.35Mkr -32.96Mkr -30.16M
Investing Cash Flow
kr 0.00kr 0.00kr 0.00kr 0.00kr -1.82M
Financing Cash Flow
kr 50.69Mkr 35.29Mkr 41.86Mkr 25.34Mkr 39.51M
End Cash Position
kr 3.04Mkr 2.08Mkr 6.15Mkr 4.14Mkr 12.20M
Free Cash Flow
kr 0.00kr -35.70Mkr -41.35Mkr -32.96Mkr -31.99M
Currency in SEK

Enorama Pharma AB Cash Flow